Key result
Although evidence shows beta-blockers reduce mortality by about 36% when added to ACE inhibitors in heart failure, clinicians remain reluctant to prescribe them, especially in older patients.
Why the study?
Do beta-blockers reduce mortality in older patients with heart failure when added to ACE inhibitors?
Population
Patients with heart failure, particularly older patients
Design
Review
Authors
Loading...
May reduce prescribing reluctance in older HF patients on ACE inhibitors; leaves real-world adoption barriers open.
Do beta-blockers reduce mortality in older patients with heart failure when added to ACE inhibitors?
This review highlights the overwhelming evidence for a 36% mortality reduction with beta-blockers in heart failure, aiming to overcome clinician reluctance to prescribe them, especially in older patients.
Syamasis Bandyopadhyay (2002) conducted a review in Heart failure. Beta-blockers was evaluated. Although evidence shows beta-blockers reduce mortality by about 36% when added to ACE inhibitors in heart failure, clinicians remain reluctant to prescribe them, especially in older patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: